In early December 2011, an advisory panel of the Federal Drug and Administration (FDA) convened for 9 hours of hearings concerning the increased risk of blood clots for users of Yaz and Yasmin. It was reported that several independent studies found women who took Yaz and/or Yasmin were more likely to suffer a blood clot than women taking other forms of birth control, which do not contain the hormone drospirenone. Following testimony, the panel voted 21 to 5 that the label was inadequate and should be changed by Bayer to explain the increased risk. Eleven experts also voted for a Yaz recall, but were out-voted by the other 15 members who opined that the benefits outweighed the risks. To date, Bayer has failed to issue a voluntary recall.
As previously reported, other possible side effects of Yaz and/or Yasmin also include heart attack, pulmonary embolism and stroke.
Currently, more than 10,000 suits have been filed nationwide.
If you feel you have experienced any side-effects from taking YAZ® or Yasmin®, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against the YAZ® or Yasmin® manufacturers.